BRAF and differentiated thyroid carcinoma: The Bethesda results (49 results) for the collected BRAF samples were as follows: from 15 patients with Bethesda I, one patient was diagnosed with papillary microcarcinoma (6.66%);of the 27 patients with Bethesda II, 3 patients were diagnosed with papillary carcinoma (11.11%);of the 5 patients with Bethesda III,1 (20%) was confirmed as havingminimally invasive follicular carcinoma;there were no patients with Bethesda IV and VI, and 2 patients with Bethesda V were confirmed as having the papillary thyroid carcinoma follicular variant.